These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3622088)

  • 1. [Failure to treat chronic asymptomatic hepatitis B virus carriers with short-term prednisone and adenine-arabinoside].
    Luo KX; Liang CS; Lin RH
    Zhonghua Nei Ke Za Zhi; 1987 Mar; 26(3):162-4, 190-1. PubMed ID: 3622088
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates.
    Thomas HC; Scully LJ; Lever AM; Yap I; Pignatelli M
    Infection; 1987; 15 Suppl 1():S26-31. PubMed ID: 2439462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of the chronic hepatitis B virus carrier state.
    Lever AM
    J Infect; 1988 May; 16(3):221-9. PubMed ID: 2456355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of adenine arabinoside (vidarabine) in the treatment of periarteritis nodosa associated with chronic active viral hepatitis B].
    Le Quellec A; Bories P; Bauret P; Piera S; Ouzan D; Trepo C; Michel H
    Gastroenterol Clin Biol; 1986 Oct; 10(10):687-8. PubMed ID: 2878855
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.
    Perrillo RP; Regenstein FG; Bodicky CJ; Campbell CR; Sanders GE; Sunwoo YC
    Gastroenterology; 1985 Mar; 88(3):780-6. PubMed ID: 2578421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers.
    Renou C; Cadranel JF; Pariente A; Pénaranda G; Bourlière M; Halfon P; Igual JP; Harafa A; Muller P; Bertrand JJ; Laugier R
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1235-7. PubMed ID: 18989147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
    Thomas HC; Lever AM; Scully LJ; Pignatelli M
    Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
    Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA
    Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study.
    Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1446-9. PubMed ID: 7680158
    [No Abstract]   [Full Text] [Related]  

  • 11. [Should chronic active viral hepatitis be treated with drugs or not?].
    Schalm SW
    Internist (Berl); 1981 Dec; 22(12):717-20. PubMed ID: 7033161
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination.
    Sacks SL; Scullard GH; Pollard RB; Gregory PB; Robinson WS; Merigan TC
    Antimicrob Agents Chemother; 1982 Jan; 21(1):93-100. PubMed ID: 6177285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis.
    Rakela J; Redeker AG; Weliky B
    Gastroenterology; 1983 May; 84(5 Pt 1):956-60. PubMed ID: 6832570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent cure of hepatitis C virus carrier state after hepatitis B virus superinfection.
    Yoshinaga S; Fukushima S; Masaki N; Hayashi S
    Jpn J Infect Dis; 1999 Oct; 52(5):220. PubMed ID: 10680091
    [No Abstract]   [Full Text] [Related]  

  • 15. [What treatment of chronic hepatitis caused by the hepatitis B virus?].
    Ouzan D
    Gastroenterol Clin Biol; 1988 Nov; 12(11):823-6. PubMed ID: 2464519
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the antiviral effects of adenine arabinoside on chronic HBV infection.
    Watanabe S; Saito S; Yoshikawa A; Shibayama T; Kamimura T; Suzuki S; Ischida F
    Hepatogastroenterology; 1982 Jun; 29(3):102-5. PubMed ID: 7106692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B-associated membranous glomerulonephritis treated with adenine arabinoside monophosphate.
    Esteban R; Buti M; Vallés M; Allende H; Guardia J
    Hepatology; 1986; 6(4):762-3. PubMed ID: 2426174
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of chronic hepatitis (author's transl)].
    Auer IO
    Leber Magen Darm; 1980 Oct; 10(5):251-8. PubMed ID: 6162069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between ADCC effector cells and the combination therapy of pantethine and lecithin--a proposal for management of patients with HBsAg carrier state (author's transl)].
    Murata T; Oniki H; Kimura Y; Komoda T; Yamashita Y; Nakamura S; Koga Y
    Igaku Kenkyu; 1981 Oct; 51(4):213-23. PubMed ID: 7331739
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B immune globulin (HBIG): efficacy in the interruption of vertical transmission of hepatitis B virus (HBV) carrier state.
    Pongpipat D; Suvatte V; Assateerawatts A
    J Med Assoc Thai; 1983 Jan; 66(1):49-53. PubMed ID: 6220098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.